Clinical Trials Logo

Chronic Obstructive Pulmonary Disease clinical trials

View clinical trials related to Chronic Obstructive Pulmonary Disease.

Filter by:

NCT ID: NCT03611036 Recruiting - COPD Clinical Trials

Effect of Different Form of Upper Limb Muscles Training on Dyspnea in COPD

REHABSUP
Start date: November 21, 2018
Phase: N/A
Study type: Interventional

Evaluate the effect of upper limbs strength training versus the effect of upper limbs endurance training, on dyspnea, in patients with COPD during a pulmonary rehabilitation program.

NCT ID: NCT03610659 Completed - COPD Clinical Trials

Validity and Reliability of The Turkish Version of Assessment of Burden of COPD Scale

Start date: June 23, 2018
Phase:
Study type: Observational

In our study, we aimed to evaluate the validity and reliability of the Turkish version of theAssessment of Burden of COPD (ABC) Scale.

NCT ID: NCT03604952 Completed - COPD Clinical Trials

Effects of Ramadan Observance in Male Patients With Chronic Obstructive Pulmonary Disease

Start date: June 18, 2015
Phase:
Study type: Observational [Patient Registry]

Purpose: To analyze the effects of Ramadan observance (RO) on pulmonary variables, exercise performance and postural balance in patients with chronic obstructive pulmonary disease (COPD). Methods: Twenty COPD patients (age=72.7 ± 4.1 yr, non-smokers, without cardiac or neuromuscular complications) were evaluated. Tests performed one week before Ramadan (C), and during the second (R-2) and the fourth weeks of Ramadan (R-4) included standard spirometry, a quality of life questionnaire (VQ11), a 6-min walking test (6MWT), measurement of maximal voluntary contraction force of the quadriceps (MVC), Timed Get Up and Go (TUG), Berg Balance Scale (BBS) and Unipedal Stance (UST).

NCT ID: NCT03604146 Completed - COPD Clinical Trials

Quality Control for Chronic Obstructive Pulmonary Disease

Start date: March 20, 2018
Phase:
Study type: Observational

This is a 1 year longitudinal study to establish a related index system for chronic obstructive pulmonary disease(COPD) quality control.Clinical and economic data of COPD patients will be collected and analyzed.

NCT ID: NCT03601403 Active, not recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Tablet-assisted Training in Exacerbated COPD

Start date: December 1, 2017
Phase: N/A
Study type: Interventional

Chronic obstructive pulmonary disease (COPD) is a public health problem with great morbidity. The main therapeutic strategy is inhalers. The objective of this study is to determine the efficacy of a tablet-assisted training in the use of inhalers in patients with COPD including ventilatory re-education and video recordings of the patients themselves.

NCT ID: NCT03591978 Recruiting - COPD Clinical Trials

Isolation of Circulating Pulmonary Cells in COPD and Its Relationship With Clinical Relevant Outcomes (IbICEnCa)

IbICEnCa
Start date: May 1, 2019
Phase:
Study type: Observational

We have demonstrated for the very first time that it is possible to isolate CPCs (circulating pulmonary cells) in patients with COPD in a sample of 17 patients (with a recovery rate of nearly 40%) and none of 10 healthy, non- smokers controls with a patented method [provisional Spanish Patent Application (P201730724)], based on liquid biopsy methodology (Romero Palacios et at, submitted 2017), showing that patients with COPD and isolation of CPCs have a more severe disease (expressed as higher BODEx index) and a trend towards a higher rate of decline of lung function as well as an increased rate of exacerbations, suggesting that CPCs isolation could be of value as a diagnostic and prognostic tool identifying patients with more active diseases. However, due to the small sample, no definitive conclusions could be made. Moreover, as there were no healthy smokers included in this study, we couldn´t evaluate if CPCs could be isolated in this type of population. The fact that CPCs could be isolated in a group of patients with COPD and its relationship with greater severity suggests that this could be a marker of progression of the disease and could detect those patients more likely to benefit from newer antiinflamatory therapies(17)

NCT ID: NCT03591562 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Imaging Progression of Chronic Obstructive Pulmonary Disease Using MRI and CT (MR-COPDII)

MR-COPDII
Start date: November 10, 2017
Phase:
Study type: Observational

In this follow-up trial, MRI and CT images of the lung will be acquired prospectively in a subcohort of 370 patients, three years after they successfully participated in the first COSYCONET subtrial with CT and MRI ("MR-COPD I", NCT (clinical.Trials.gov identifier) 02629432). The objective is to obtain longitudinal data from a well-characterized collective of COPD patients in order to identify suitable image-based biomarkers to improve the prognosis of disease progression of COPD in comparison to clinical tests

NCT ID: NCT03591263 Recruiting - Clinical trials for Chronic Obstructive Pulmonary Disease

Clinical Outcomes in Patients Referred to Pulmonary Rehabilitation

Start date: June 25, 2018
Phase:
Study type: Observational

Chronic obstructive pulmonary disease is a chronic inflammatory lung disease that causes obstructed airflow from the lung, characterized by chronic cough, dyspnea, and sputum production, which often misunderstood as aging or catching a cold. These symptoms may be progressive over time. To provide better disease management and early detecting, pulmonary rehabilitation is now considered a fundamental component of the integrated disease management of this population. However, few studies have evaluated the beneficial outcomes in patients referred to pulmonary rehabilitation. Therefore, the purpose of this study is to investigate the clinical outcomes in patients referred to pulmonary rehabilitation in National Taiwan University Hospital.

NCT ID: NCT03590379 Completed - Clinical trials for Chronic Obstructive Pulmonary Disease

Efficacy of Fixed Combination of Beclomethasone Dipropionate (BDP) + Formoterol Fumarate (FF) + Glycopyrronium Bromide (GB) (CHF 5993)Administered Via Dry Powder Inhaler (DPI) in Chronic Obstructive Pulmonary Disease (COPD)

TRI-D
Start date: June 15, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the efficacy of Fixed Combination of Beclomethasone Dipropionate + Formoterol Fumarate + Glycopyrronium Bromide Administered Via Dry Powder Inhaler in COPD

NCT ID: NCT03584269 Terminated - Clinical trials for Chronic Obstructive Pulmonary Disease

Innovation in NOn Invasive Ventilation in COPD Patients Treated by Long Term Oxygen Therapy

INOV-LTOT
Start date: June 28, 2018
Phase: N/A
Study type: Interventional

The aim of this study is to investigate the efficacy of non-invasive ventilation (NIV) on nocturnal hypoventilation in patients with chronic obstructive pulmonary disease (COPD) who are on long term oxygen therapy (LTOT) at home.